MedTrace Logo

Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study

NCT01728883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-05-12

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of enhancements to the myVisionTrack® in regards to patient compliance and test-retest variability. Additionally, the ability of myVisionTrack® to detect changes in vision function will be evaluated.

Conditions

Interventions

DEVICE

Home vision monitoring using myVisionTrack®

Patients will be asked to test their vision at home twice per week using myVisionTrack® during the study period.

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Retina Foundation of the Southwest

    collaborator OTHER

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • Texas Retina Associates

    collaborator OTHER

  • Vital Art and Science Incorporated

    lead INDUSTRY

Principal Investigators

  • Yi-Zhong Wang, PhD · Retina Foundation of the Southwest

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-04-30
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01728883 on ClinicalTrials.gov